Source: MarketScreener

Taisho Pharmaceutical Co., Ltd.: Curi RMB, Kaname to ask Tokyo court to revise Taisho Pharma squeeze-out price, Nikkei reports

(marketscreener.com) Curi RMB Capital and Kaname Capital will ask a Tokyo court to revise up the squeeze-out price for Taisho Pharmaceutical's shares upon its management buyout if the company disagrees with their demands, the Nikkei newspaper reported on Monday. Taisho announced earlier in the day that its extraordinary shareholders' meeting had approved...https://www.marketscreener.com/quote/stock/TAISHO-PHARMACEUTICAL-HOL-10587050/news/Curi-RMB-Kaname-to-ask-Tokyo-court-to-revise-Taisho-Pharma-squeeze-out-price-Nikkei-reports-46218954/?utm_medium=RSS&utm_content=20240318

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
1-25
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more